From 1 January 2025, the Windsor Framework will simplify medicine licensing across the UK. The MHRA will issue UK-wide licenses, replacing separate ones for Great Britain and Northern Ireland. Medicines will have the same packaging across the country.
The Medicines and Healthcare products Regulatory Agency (MHRA) is inviting feedback on plans to end use of the European Commission Decision Reliance Procedure (ECDRP) to bring medicines to market.
The new report, ‘Promoting population health through pharmaceutical policy: The role of the UK Voluntary Scheme’, produced by researchers at the London School of Economics, London School of Hygiene & Tropical Medicine (LSHTM) and University of York, investigates the costs of prescription medicines to the NHS in England.
